Rebecca Geck
Family · Houston, TXNPI 1306228176
Payments from drug & device makers
What this record shows
AbbVie accounts for 60.3% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $5,417 and has fallen 78.2% since, to $1,180 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $59.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Gilead$620
- Sanofi$319
- Inspire Medical Systems, Inc.$315
- Lundbeck LLC$202
- Upsher-smith Laboratories LLC$195
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$4,30049%
- Food & beverage$4,49251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $5,305 |
| Gilead | 6 | $620 |
| Sanofi | 3 | $319 |
| Inspire Medical Systems, Inc. | 3 | $315 |
| Lundbeck LLC | 8 | $202 |
| Upsher-smith Laboratories LLC | 32 | $195 |
| AstraZeneca | 2 | $180 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Abbott | 1 | $137 |
| Silk Road Medical, Inc. | 1 | $134 |
| Biohaven Pharmaceuticals, Inc. | 7 | $126 |
| Acadia Pharmaceuticals Inc | 1 | $121 |
| Lilly USA, LLC | 8 | $115 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Novo Nordisk | 1 | $97 |
| Ultragenyx Pharmaceutical Inc. | 1 | $94 |
| Edwards Lifesciences | 1 | $90 |
| Scynexis, Inc. | 1 | $86 |
| Abiomed | 1 | $82 |
| Jazz Pharmaceuticals Inc. | 1 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| Coloplast | 2 | $63 |
| Pfizer | 1 | $40 |
| Viiv Healthcare Company | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,792 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.